Benefits of continued cyclosporine through an indigent drug program-Reference-Cited by-同舟云学术

Benefits of continued cyclosporine through an indigent drug program

Published:1996-10 Issue:4 Volume:28 Page:572-577
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Sanders Charles E.,Julian Bruce A.,Gaston Robert S.,Deierhoi Mark H.,Diethelm Arnold G.,Curtis John J.

Publisher

Elsevier BV

Subject

Nephrology

Reference27 articles.

1. Tapering or discontinuing cyclosporine for financial reasons-A single center experience;Sanders;Am J Kidney Dis,1993

2. Racial differences in the survival of cadaveric renal allografts;Butkus;N Engl J Med,1992

3. Noncompliance in organ transplant recipients;Schweizer;Transplantation,1990

4. Radionuclide evaluation of renal transplants;Dubovsky;Semin Nucl Med,1988

5. Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathioprine;Opelz;Transplant Proc,1993

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade;Expert Opinion on Pharmacotherapy;2017-05-09

2. Adherence to the Medical Regimen During the First Two Years After Lung Transplantation;Transplantation;2008-01-27

3. Racial Disparities in Renal Allograft Survival: A Public Health Issue?;Journal of the American College of Surgeons;2007-05

4. Kidney Transplant in Black Recipients: Are African Europeans Different from African Americans?;American Journal of Transplantation;2005-11

5. Health Disparities in Transplantation: Focus on the Complexity and Challenge of Renal Transplantation in African Americans;Medical Clinics of North America;2005-09